Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

BLTEBLTE
8 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in Belite Bio, Inc. ADR

CITADEL ADVISORS LLC holds 186,168 shares of BLTE (Belite Bio, Inc. ADR), worth $28.7M as of 2026-Q2. The position was increased (+9171.3% shares). BLTE represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$28.7M

Current Shares

186,168

Total Value Change

+$28.4M

Total Shares Change

+179,708

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
186,168
+9171.3%
$28.7M0.0%$153.99
46
2026-Q1
Decreased
2,008
-60.3%
$320,1560.0%$167.88
0
2025-Q4
Decreased
5,055
-53.3%
$808,5980.0%$160.82
0
2025-Q3
Increased
10,827
+45.2%
$801,1980.0%$73.00
34
2025-Q2
Increased
7,456
+31.1%
$430,2110.0%$59.04
30
2025-Q1
Increased
5,689
+9.2%
$376,7260.0%$66.70
26
2024-Q4
Decreased
5,211
-19.3%
$328,8140.0%$61.97
0
2024-Q3
New
6,460
-
$302,8450.0%$46.55
32

Other major holders of BLTE: UBS Group AG, RTW INVESTMENTS, LP, MILLENNIUM MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used